Thriving Through Transitions in JIA Care: The Vital Role of Advanced Practice Providers

Important: This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members. You must be logged in to use your NAPNAP member ID# and password to be recognized as a member of NAPNAP. If you are a current member of NAPNAP and you are being asked to purchase this activity, please contact the NAPNAP national office at (877) 662-7627 to request assistance prior to entering any information.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question(s) to: ce@napnap.org.

Additional Downloadable Resources

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an agency providing continuing education credit. Individuals who complete this program and earn 70% or higher on the post test will be awarded 1.0 NAPNAP contact hours of which 0.25 is pharmacology content.

This activity was developed by Med-IQ in collaboration with AAPA and NAPNAP.


  and 

Statement of Need

Juvenile idiopathic arthritis (JIA) is an arthritis of unknown origin that affects approximately 300,000 children and teens in the United States. JIA has a serious impact on quality of life and can continue into adulthood in some patients. The diagnosis of JIA is challenging, as it is a diagnosis of exclusion and can easily be missed, often leading to a delay in treatment. 

The management of JIA involves a multidisciplinary team that typically includes a rheumatologist; however, an ongoing and increasing shortage of rheumatology professionals necessitates the involvement of advanced practice providers—including nurse practitioners and physician assistants—in the management and transitioning of care from pediatric to adult care settings. 

Finally, the current state of care is evolving with new therapies and emerging guidelines, and clinicians who manage patients with JIA must remain up to date on available therapies and treatment recommendations.

Statement of Support

This activity is supported by an educational grant from Pfizer.

Copyright © Med-IQ.

Target Audience

This activity is intended for advanced practice providers (NPs and clinical nurse specialists) who may be involved in the care and treatment of patients with JIA.

Learning Objectives

  • Describe the clinical presentation and diagnosis of JIA
  • Evaluate the efficacy, safety, and role of DMARDs in the management of JIA, including new treatments and guidelines
  • Discuss the importance of appropriate transition from pediatric to adult care
     
Course summary
Available credit: 
  • 1.00 Contact hours
Course opens: 
02/04/2022
Course expires: 
02/04/2023
Cost:
$0.00
Rating: 
0

Faculty

Heather M. Benham, DNP, APRN, CPNP-PC 
Pediatric Rheumatology NP
Scottish Rite Hospital for Children 
Dallas, TX 

Vy Khanh Do, DO, MPH
Pediatric Rheumatologist
Dell Children's Medical Center of Central Texas
Dell Medical School at The University of Texas at Austin
Austin, TX

Heather Finlayson, PA
Rheumatology PA
Colorado Arthritis Associates
Lakewood, CO

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  
  
Heather M. Benham, DNP, APRN, CPNP-PC, has indicated no real or apparent conflicts. 

Vy Khanh Do, DO, MPH has indicated no real or apparent conflicts. 

Heather Finlayson, PA
Consulting fees/advisory boards: Aurinia Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc.
Fees received for promotional/non-CE activities: AstraZeneca, GlaxoSmithKline

Off-label Use

Off-label/unapproved drug uses or products are mentioned within this activity.

Activity Planners

Julie Blum, PhD
Director, Clinical Content
Med-IQ
Baltimore, MD

Samantha Gordon, MS
Accreditation Manager 
Med-IQ
Baltimore, MD

Laura Nelsen
Director of Education & Learning
National Association of Pediatric Nurse Practitioners
New York, NY

Karlee Renninger, PMP
Project Manager, Education and Quality
American Academy of Physician Associates
Alexandria, VA

The peer reviewers and activity planners have no financial relationships to disclose.

 

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an agency providing continuing education credit. Individuals who complete this program and earn 70% or higher on the post test will be awarded 1.0 NAPNAP contact hours of which 0.25 is pharmacology content.

Statement of Evidence-based Content
Educational activities that assist advanced practice registered nurses in carrying out their professional responsibilities more effectively and efficiently are consistent with the NAPNAP definition of continuing education (CE). NAPNAP accredited programs have been reviewed to ensure that all content and any recommendations, treatments, and manners of practicing health care are current, scientifically based, valid, and relevant to the advanced practice of nursing. NAPNAP is responsible for validating the content of the CE activities they provide. Specifically, all recommendations addressing the health care of patients must be based on evidence that is scientifically sound and recognized as such within the profession. NAPNAP is not liable for any decision made or action taken in reliance upon the information provided through a NAPNAP accredited activity.

Available Credit

  • 1.00 Contact hours

Price

Cost:
$0.00
Please login or register to take this course.